Martens WB - Search Results

1

Diagnostic odyssey of patients with myotonic dystrophy.

Hilbert JE, Ashizawa T, Day JW, Luebbe EA, Martens WB, McDermott MP, Tawil R, Thornton CA, Moxley RT 3rd. Hilbert JE, et al. Among authors: martens wb. J Neurol. 2013 Oct;260(10):2497-504. doi: 10.1007/s00415-013-6993-0. Epub 2013 Jun 27. J Neurol. 2013. PMID: 23807151 Free PMC article.

2

Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1).

Moxley RT 3rd, Logigian EL, Martens WB, Annis CL, Pandya S, Moxley RT 4th, Barbieri CA, Dilek N, Wiegner AW, Thornton CA. Moxley RT 3rd, et al. Among authors: martens wb. Muscle Nerve. 2007 Sep;36(3):320-8. doi: 10.1002/mus.20822. Muscle Nerve. 2007. PMID: 17587223

3

An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients.

O'Hagen JM, Glanzman AM, McDermott MP, Ryan PA, Flickinger J, Quigley J, Riley S, Sanborn E, Irvine C, Martens WB, Annis C, Tawil R, Oskoui M, Darras BT, Finkel RS, De Vivo DC. O'Hagen JM, et al. Among authors: martens wb. Neuromuscul Disord. 2007 Oct;17(9-10):693-7. doi: 10.1016/j.nmd.2007.05.009. Epub 2007 Jul 19. Neuromuscul Disord. 2007. PMID: 17658255

4

Inclusion body myositis functional rating scale: a reliable and valid measure of disease severity.

Jackson CE, Barohn RJ, Gronseth G, Pandya S, Herbelin L; Muscle Study Group. Jackson CE, et al. Muscle Nerve. 2008 Apr;37(4):473-6. doi: 10.1002/mus.20958. Muscle Nerve. 2008. PMID: 18236463 Clinical Trial.

5

A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis.

Muscle Study Group. Muscle Study Group. Neurology. 2008 Aug 5;71(6):394-9. doi: 10.1212/01.wnl.0000312373.67493.7f. Epub 2008 Apr 23. Neurology. 2008. PMID: 18434639 Clinical Trial.

6

Less is more, or almost as much: a 15-item quality-of-life instrument for myasthenia gravis.

Burns TM, Conaway MR, Cutter GR, Sanders DB; Muscle Study Group. Burns TM, et al. Muscle Nerve. 2008 Aug;38(2):957-63. doi: 10.1002/mus.21053. Muscle Nerve. 2008. PMID: 18642357

7

Disease-specific measure of quality of life for myasthenia gravis.

Mullins LL, Carpentier MY, Paul RH, Sanders DB; Muscle Study Group. Mullins LL, et al. Muscle Nerve. 2008 Aug;38(2):947-56. doi: 10.1002/mus.21016. Muscle Nerve. 2008. PMID: 18697209

8

Hypothesis: neoplasms in myotonic dystrophy.

Mueller CM, Hilbert JE, Martens W, Thornton CA, Moxley RT 3rd, Greene MH. Mueller CM, et al. Cancer Causes Control. 2009 Dec;20(10):2009-20. doi: 10.1007/s10552-009-9395-y. Cancer Causes Control. 2009. PMID: 19642006 Free PMC article. Review.

9

Evoked myotonia can be "dialed-up" by increasing stimulus train length in myotonic dystrophy type 1.

Logigian EL, Twydell P, Dilek N, Martens WB, Quinn C, Wiegner AW, Heatwole CR, Thornton CA, Moxley RT 3rd. Logigian EL, et al. Among authors: martens wb. Muscle Nerve. 2010 Feb;41(2):191-6. doi: 10.1002/mus.21481. Muscle Nerve. 2010. PMID: 19750543 Free PMC article.

10

What determines quality of life in inclusion body myositis?

Sadjadi R, Rose MR; Muscle Study Group. Sadjadi R, et al. J Neurol Neurosurg Psychiatry. 2010 Oct;81(10):1164-6. doi: 10.1136/jnnp.2009.183863. Epub 2010 Jul 2. J Neurol Neurosurg Psychiatry. 2010. PMID: 20601666

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters